|Bid||20.500 x 0|
|Ask||20.600 x 0|
|Day's Range||20.300 - 21.800|
|52 Week Range||9.430 - 31.700|
|Beta (3Y Monthly)||2.34|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.50|
Amgen Inc (AMGN.O), updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. Six patients were still responding at 7.5 months of follow-up, according to research presented in San Diego at the annual meeting of the American Society of Haematology (ASH). Amgen said AMG420, which targets a protein linked to multiple myeloma known as BCMA, has been given fast track status by the U.S. Food and Drug Administration.
A Chinese biotech stock suddenly plunged as much as 47 percent in Hong Kong, attracting more turnover in the morning session than most stocks do in an entire day. While Genscript Biotech Corp. had pared losses to 27 percent before trading was suspended at 11:32 a.m., the decline wiped off about $1 billion from the company’s market value. Local media cited a bearish report from an anonymous research group that was shared on Chinese social media, though it wasn’t available on the group’s own website.
I’ve been keeping an eye on Genscript Biotech Corporation (HKG:1548) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believeRead More...
June 18 (Reuters) - Genscript Biotech Corp: * GENSCRIPT BIOTECH CORP Says UNIT ENTERED MOU WITH INNOVATION CENTER FOR IMMUNE THERAPY OF TSINGHUA UNIVERSITY FOR DISCOVERY & DEVELOPMENT OF BIOLOGICS Source ...
LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen PISCATAWAY, N.J. , May 30, 2018 /PRNewswire/ -- Legend Biotech, a subsidiary of GenScript ...
Companies such as YiChang HEC ChangJiang Pharmaceutical and Essex Bio-Technology have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolioRead More...
High growth companies such as Essex Bio-Technology and Genscript Biotech has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companies tendRead More...